Plasminogen activator inhibitor 1 and venous thrombosis in pancreatic cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Plasminogen activator inhibitor 1 and venous thrombosis in pancreatic cancer
Authors
Keywords
-
Journal
Blood Advances
Volume 5, Issue 2, Pages 487-495
Publisher
American Society of Hematology
Online
2021-01-22
DOI
10.1182/bloodadvances.2020003149
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neutrophils and neutrophil extracellular traps enhance venous thrombosis in mice bearing human pancreatic tumors
- (2019) Yohei Hisada et al. HAEMATOLOGICA
- Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancer.
- (2018) Ella Grilz et al. HAEMATOLOGICA
- Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients
- (2018) L.-M. Mauracher et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Mouse models of cancer-associated thrombosis
- (2018) Yohei Hisada et al. THROMBOSIS RESEARCH
- Arterial thrombosis and cancer
- (2018) Doron Aronson et al. THROMBOSIS RESEARCH
- Incidence and risk factors for venous thromboembolism in patients with pretreated advanced pancreatic carcinoma
- (2018) Shunsuke Kondo et al. Oncotarget
- Biomarkers for the risk of thrombosis in pancreatic adenocarcinoma are related to cancer process
- (2018) Dorothée Faille et al. Oncotarget
- Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancer.
- (2018) Ella Grilz et al. HAEMATOLOGICA
- A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts
- (2018) Ingrid Pabinger et al. Lancet Haematology
- Coagulation biomarkers and prediction of venous thromboembolism and survival in small cell lung cancer: A sub-study of RASTEN - A randomized trial with low molecular weight heparin
- (2018) E. Gezelius et al. PLoS One
- Evaluation of venous thrombosis and tissue factor in epithelial ovarian cancer
- (2017) Joshua G. Cohen et al. GYNECOLOGIC ONCOLOGY
- Human pancreatic tumors grown in mice release tissue factor-positive microvesicles that increase venous clot size
- (2017) Y. Hisada et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Tumor-Derived Exosomes Induce the Formation of Neutrophil Extracellular Traps: Implications For The Establishment of Cancer-Associated Thrombosis
- (2017) Ana C. Leal et al. Scientific Reports
- Pharmacological Targeting of Plasminogen Activator Inhibitor-1 Decreases Vascular Smooth Muscle Cell Migration and Neointima FormationHighlights
- (2016) Yan Ji et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Estimating risk of venous thromboembolism in patients with cancer in the presence of competing mortality
- (2015) C. Ay et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Tissue factor-positive tumor microvesicles activate platelets and enhance thrombosis in mice
- (2015) J. E. Geddings et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Bevacizumab promotes venous thromboembolism through the induction of PAI-1 in a mouse xenograft model of human lung carcinoma
- (2015) Ni Chen et al. Molecular Cancer
- Plasminogen activator-1 overexpression decreases experimental postthrombotic vein wall fibrosis by a non-vitronectin-dependent mechanism
- (2014) A. T. Obi et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Active PAI-1 as marker for venous thromboembolism: Case–control study using a comprehensive panel of PAI-1 and TAFI assays
- (2014) Lize Bollen et al. THROMBOSIS RESEARCH
- Biomarkers for prediction of venous thromboembolism in cancer
- (2013) I. Pabinger et al. BLOOD
- Epidemiology of cancer-associated venous thrombosis
- (2013) J. F. Timp et al. BLOOD
- Circulating microparticle tissue factor, thromboembolism and survival in pancreaticobiliary cancers
- (2013) Anubha Bharthuar et al. THROMBOSIS RESEARCH
- Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer
- (2012) J.-G. Wang et al. BLOOD
- Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States
- (2012) Alok A. Khorana et al. CANCER
- Knock-down of plasminogen-activator inhibitor-1 enhances expression of E-cadherin and promotes epithelial differentiation of human pancreatic adenocarcinoma cells
- (2012) Monica Lupu-Meiri et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients
- (2012) J. THALER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- The role of urokinase plasminogen activator and plasmin activator inhibitor-1 on vein wall remodeling in experimental deep vein thrombosis
- (2012) Joe F. Baldwin et al. JOURNAL OF VASCULAR SURGERY
- Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis
- (2012) M. Demers et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Plasminogen Activator Inhibitor-1 and Thrombotic Cerebrovascular Diseases
- (2012) Anna Tjärnlund-Wolf et al. STROKE
- Risk of Venous Thromboembolism in Patients with Cancer: A Systematic Review and Meta-Analysis
- (2012) Freesia Horsted et al. PLOS MEDICINE
- Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1
- (2010) M. E. Meltzer et al. BLOOD
- REVIEW: Plasminogen Activator Inhibitor-1 (PAI-1): A Key Factor Linking Fibrinolysis and Age-Related Subclinical and Clinical Conditions
- (2010) Matteo Cesari et al. Cardiovascular Therapeutics
- Arterial thrombosis in ambulatory cancer patients treated with chemotherapy
- (2010) Marcello Di Nisio et al. THROMBOSIS RESEARCH
- D-dimer before chemotherapy might predict venous thromboembolism
- (2009) Guido Arpaia et al. BLOOD COAGULATION & FIBRINOLYSIS
- D-Dimer and Prothrombin Fragment 1 + 2 Predict Venous Thromboembolism in Patients With Cancer: Results From the Vienna Cancer and Thrombosis Study
- (2009) Cihan Ay et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessing Risk of Venous Thromboembolism in the Patient With Cancer
- (2009) Alok A. Khorana et al. JOURNAL OF CLINICAL ONCOLOGY
- High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)
- (2008) C. Ay et al. BLOOD
- Plasminogen‐induced aggregation of PANC‐1 cells requires conversion to plasmin and is inhibited by endogenous plasminogen activator inhibitor‐1
- (2008) Naamit Deshet et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer
- (2008) A. A. KHORANA et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started